You can buy or sell Illumina and other stocks, options, ETFs, and crypto commission-free!
Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). Read More The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Current Valuation: Illumina (NASDAQ: ILMN)
Illumina trades as part of the healthcare sector and medical diagnostics and research industry. The company CEO is Francis A. DeSouza. Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products. Previous Intraday Trading Performance: The ILMN stock showed a previous change of -3.26% with an open at 319.08 and a close of 308.79. I...
The Motley FoolMar 21
Better Buy: Illumina vs. Guardant Health
Thanks to scientific breakthroughs, we're living in an age of miracles, according to David Gardner, cofounder of The Motley Fool.
Simply Wall StMar 20
What Investors Should Know About Illumina, Inc.’s (NASDAQ:ILMN) Financial Strength
Investors pursuing a solid, dependable stock investment can often be led to Illumina, Inc. (NASDAQ:ILMN), a large-cap worth US$46b. Big corporations are much sought after by risk-averse investors who find diversified revenue streams and strong capital returns attractive. However, its financial health remains the key to continued success. This article will examine Illumina’s financial liquidity and debt levels to get an idea of whether the company can deal with cyclical downturns and maintain funds to accomm...
Expected Apr 23, After Hours